Guillain- Barre Syndrome: A Rare Immune Mediated Polyneuropathy

Published on:November 2017
Indian Journal of Pharmacy Practice, 2017; 10(3):230-232
Case Report | doi:10.5530/ijopp.10.3.47

Guillain- Barre Syndrome: A Rare Immune Mediated Polyneuropathy

Authors and affiliation (s):

Nama Ravi Sneha Keerthi*, Neelathahalli Kasturirangan Meera

Department of Pharmacy Practice, Visveswarapura Institute of Pharmaceutical Sciences, Bengaluru, Karnataka, INDIA.


Guillain-Barré syndrome (GBS) is a rare autoimmune disorder associated with demyelinating polyneuropathy requiring early diagnosis and accurate treatment. From birth to 30 years, the annual incidence is fairly uniform at 1.3 to 1.9 per 100,000. Clinical hallmarks include symmetrical flaccid muscle paresis and areflexia in the presence of an increased cerebrospinal fluid protein and electrophysiologic studies demonstrating demyelination. A case of 29 year old female presenting to a tertiary care hospital with GB syndrome and hypothyroidism is described. The significance of an appropriate diagnosis by the physician and subsequent management by the clinical staff is reviewed.

Key words: Autoimmune, Areflexia, Demyelination, Demyelinating polyneuropathy, Flaccid muscle paresis, Hypothyroidism.


The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.


IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs